NeuroVive Pharmaceutical AB SMA 200
Was ist das SMA 200 von NeuroVive Pharmaceutical AB?
SMA 200 von NeuroVive Pharmaceutical AB ist kr0 +6.37%
Was ist die Definition von SMA 200?
SMA 200 ist ein durchschnittlicher Aktienkurs der letzten 200 Tage, berechnet als ungewichteter Mittelwert der letzten 200 Schlusskurse.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu NeuroVive Pharmaceutical AB
Was macht NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Unternehmen mit sma 200 ähnlich NeuroVive Pharmaceutical AB
- Silver Dollar Resources Inc hat SMA 200 von $0 -17.67%
- Sheng Yuan hat SMA 200 von HKD$0 -11.64%
- Tsodilo Resources hat SMA 200 von CAD$0 -95.37%
- Argo International hat SMA 200 von $0 -30.36%
- Stampede Drilling hat SMA 200 von CAD$0 -11.74%
- Stealth Global hat SMA 200 von AUD$0 +32.96%
- NeuroVive Pharmaceutical AB hat SMA 200 von kr0 +6.37%
- GORE German Office Real Estate AG hat SMA 200 von €0 -209.45%
- Gemini Investments () hat SMA 200 von HKD$0 +1.88%
- Wisdom Education International hat SMA 200 von HKD$0 -59.19%
- Avant Brands Inc hat SMA 200 von CAD$0 +79.69%
- Element 25 hat SMA 200 von AUD$0 -20.91%
- BCI Minerals hat SMA 200 von AUD$0 +11.02%